ALK and neuroblastoma: However, the mechanisms that triggers the accumulation of chromosomal alterations leading to NB at such an early age is still not clear, and only a few specific genes in regions affected by recurrent segmental aberrations are identified to have clinical and therapeutic impact (e.g. ALK, TERT, ATRX or CDKN2A/B) [12–15].